The New USPSTF Mammography Recommendations - A Dissenting View.

N Engl J Med

From the Dartmouth Institute and Dartmouth Cancer Center, Lebanon, NH (S.W.); the Lisa Schwartz Foundation for Truth in Medicine, Norwich, VT (S.W., K.J.J., S.H., H.G.W.); Cochrane Denmark and the Center for Evidence-Based Medicine Odense, Department of Clinical Research, University of Southern Denmark, Odense (K.J.J.); the Department of Surgery, Duke University, Durham, NC (S.H.); and the Center for Surgery and Public Health, Department of Surgery, Brigham and Women's Hospital, Boston (H.G.W.).

Published: September 2023

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp2307229DOI Listing

Publication Analysis

Top Keywords

uspstf mammography
4
mammography recommendations
4
recommendations dissenting
4
dissenting view
4
uspstf
1
recommendations
1
dissenting
1
view
1

Similar Publications

What does cancer screening have to do with tomato growing?

Clin Chem Lab Med

January 2025

Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Sinai Health System, Toronto, Canada.

Cancer screening is considered to be a major strategy for combatting cancer. The United States Preventive Services Task Force (USPSTF) recommends screening for five cancers, but the strength of evidence about the effectiveness of screening is limited. To gain insights into the efficacy of early detection requires prospective, blinded, placebo-controlled clinical trials with decades of follow-up and inclusion of millions of participants.

View Article and Find Full Text PDF

US Preventive Services Task Force; Nicholson WK, Silverstein M, Wong JB, et al. JAMA. 2024;331:1918-1930.

View Article and Find Full Text PDF

Background: The U.S. Preventive Services Task Force (USPSTF) recently changed its recommendation for mammography screening from informed decision making to biennial screening for women aged 40 to 49 years.

View Article and Find Full Text PDF

Screening for Breast Cancer: A Comparative Review of Guidelines.

Life (Basel)

June 2024

Third Department of Obstetrics and Gynecology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.

Article Synopsis
  • Breast cancer is the most common cancer in women globally and a leading cause of death in perimenopausal women, making early detection through screening crucial for reducing mortality.
  • A study reviewed 14 different breast cancer screening guidelines from 2014 to 2022, highlighting the consensus that mammography is the gold standard for average-risk women.
  • Most guidelines recommend annual or biennial screening starting between ages 40-74, with some discrepancies for high-risk women regarding when to start and the frequency of advanced imaging methods like MRI.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!